Movement Alert|Molina Healthcare Intraday Rise 5.54%, RBC Initiation With $216 Target Boosts Sentiment

Market Focus06-25

On June 25, Molina Healthcare rose 5.54% in regular trading, trading at $212.58 USD/share, with turnover of $42.47 million. The rally was driven by RBC Capital's initiation of coverage on June 23, assigning a Sector Perform rating with a $216 price target.

RBC highlighted that Molina has a clear path to earnings growth through 2027, supported by the reversal of Florida CMS startup costs, exit from Medicare Advantage Prescription Drug plans, and operating leverage from approximately $6 billion in new revenue. Management expects at least $4.50 per share in embedded 2027 earnings, with RBC's adjusted EPS estimate of $9.60 broadly in line with company outlook. At its Investor Day, Molina projected adjusted EPS of $25 and premium revenue of $64 billion by 2029. Additionally, the company recently secured an Illinois Medicaid managed care contract covering approximately 3.1 million beneficiaries, effective January 2027. Multiple other firms including UBS ($202 target), Truist ($205 target), and Morgan Stanley ($167 target) have also raised price targets in recent months.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment